KPTI Karyopharm Therapeutics Inc

USD 1.5650 0.09 (+5.74%)
Icon

Karyopharm Therapeutics Inc (KPTI) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.48

+0.09 (+6.47)%

USD 0.16B

1.30M

USD 5.00(+237.84%)

USD 4.75 (+220.95%)

Icon

KPTI

Karyopharm Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.5650
0.09 (+5.74%)
As of 03:13PM EDT.
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.16B

USD 4.75 (+220.95%)

USD 1.48

Karyopharm Therapeutics Inc (KPTI) Stock Forecast

Show ratings and price targets of :
USD 5.00
(+237.84%)

Based on the Karyopharm Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for Karyopharm Therapeutics Inc is USD 5.00 over the next 12 months. Karyopharm Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Karyopharm Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Karyopharm Therapeutics Inc’s stock price was USD 1.48. Karyopharm Therapeutics Inc’s stock price has changed by +5.71% over the past week, +4.96% over the past month and -57.59% over the last year.

No recent analyst target price found for Karyopharm Therapeutics Inc
No recent average analyst rating found for Karyopharm Therapeutics Inc

Company Overview Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel an...Read More

https://www.karyopharm.com

85 Wells Avenue, Newton, MA, United States, 02459-3298

325

December

USD

USA

Adjusted Closing Price for Karyopharm Therapeutics Inc (KPTI)

Loading...

Unadjusted Closing Price for Karyopharm Therapeutics Inc (KPTI)

Loading...

Share Trading Volume for Karyopharm Therapeutics Inc Shares

Loading...

Compare Performance of Karyopharm Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for KPTI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Karyopharm Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing KPTI

Symbol Name KPTI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Karyopharm Therapeutics Inc (KPTI) Stock

Based on ratings from 4 analysts Karyopharm Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on KPTI's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for KPTI is USD 5.00 over the next 12 months. The maximum analyst target price is USD 8 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on KPTI's stock to indicate if its overvalued.

The last closing price of KPTI's stock was USD 1.48.

The most recent market capitalization for KPTI is USD 0.16B.

Based on targets from 4 analysts, the average taret price for KPTI is projected at USD 5.00 over the next 12 months. This means that KPTI's stock price may go up by +237.84% over the next 12 months.

We can't find any ETFs which contains Karyopharm Therapeutics Inc's stock.

As per our most recent records Karyopharm Therapeutics Inc has 325 Employees.

Karyopharm Therapeutics Inc's registered address is 85 Wells Avenue, Newton, MA, United States, 02459-3298. You can get more information about it from Karyopharm Therapeutics Inc's website at https://www.karyopharm.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...